BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Pancreatic Cancer Clinical Trial Data for Diakonos Oncology’s DOC1021 Cell-Based Immunotherapy to be Presented at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

  October 28, 2025

   · 

  2 min read
• Press Releases

  New study reveals substantial unmet need in psoriasis, shows strong patient and provider preference for highly effective oral treatments with favorable safety profile

  October 28, 2025

   · 

  6 min read
• Press Releases

  Acurx Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 12, 2025 Conference Call and Provide Business Update

  October 28, 2025

   · 

  4 min read
• Press Releases

  New Study Demonstrates Accuracy of Two Quest AD-Detect® Tests for Alzheimer’s Disease Diagnosis

  October 28, 2025

   · 

  4 min read
• Press Releases

  Corsera Health Files First Phase 1 Clinical Trial Application for its Lead Preventive RNAi Medicine Program for Cardiovascular Disease

  October 28, 2025

   · 

  3 min read
• Press Releases

  Wilmington PharmaTech Appoints Industry Veteran Kent Payne as Managing Director and Board Member

  October 28, 2025

   · 

  4 min read
• Press Releases

  Geron Plans to Announce Third Quarter 2025 Financial Results on November 5, 2025

  October 28, 2025

   · 

  1 min read
• Press Releases

  Kivu Bioscience Appoints Sophia Randolph, M.D., Ph.D., as Chief Medical Officer

  October 28, 2025

   · 

  2 min read
• Press Releases

  AtriCure to Participate in Upcoming November 2025 Investor Conferences

  October 28, 2025

   · 

  1 min read
• Press Releases

  Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025

  October 28, 2025

   · 

  3 min read